Re: AACR 2018

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AACR 2018

in response to

AACR 2018

BearDownAZ

posted on Feb 21, 2018 11:38AM

Later today (4:30 p.m. ET), the titles for accepted "Regular" abstracts for AACR 2018 will be posted online. Note, titles for Late-Breaking and Clinical Trials Abstracts won't be released until March 14th. Keep an eye out today for potential BET inhibitor titles. However, I expect any ZEN-3694 clinical trial data to be in the Late-Breaking and Clinical Trials category and not the Regular category.

Feb. 21, 2018:

Online Itinerary Planner Available
Regular Abstract Titles Posted to Online Itinerary Planner

March 14, 2018:

Regular Abstracts Posted to Online Itinerary Planner (4:30 p.m. ET)
Late-Breaking and Clinical Trials Abstract Titles Posted to Online Itinerary Planner (4:30 p.m. ET)

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply